Paid Clinical Trials South Dakota
Discover 117 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
ELANA 841PAT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
Sponsor:
Carl Zeiss Meditec, Inc.
Location:
Code:
NCT06264232
Conditions
Cataract Senile
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Cataract Surgery
REACTA Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Sponsor:
Prokidney
Location:
Code:
NCT05099770
Conditions
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Renal Autologous Cell Therapy (REACT)
Sham Comparator
Observational StudyMOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.
Sponsor:
Carolyn M Hettrich
Location:
Code:
NCT02075775
Conditions
Other Instability, Shoulder
Dislocations
Subluxations
Recurrent Dislocation of Shoulder Region
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Dipraglurant with LevodopaDipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor:
Addex Pharma S.A.
Location:
Code:
NCT04857359
Conditions
Parkinson Disease
Dyskinesia, Drug-Induced
Dyskinesias
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Dipraglurant
Placebo
enVista® BeyondStudy to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
Sponsor:
Bausch & Lomb Incorporated
Location:
Code:
NCT06333015
Conditions
Cataract
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
enVista EY Beyond IOL
enVista MX60E monofocal IOL
Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
Novel Sling vs. Traditional SlingComparison Of A Novel Sling With A Traditional Abduction Sling After Shoulder Surgery
Sponsor:
Orthopedic Institute, Sioux Falls, SD
Location:
Code:
NCT05274737
Conditions
Rotator Cuff Tears
Osteo Arthritis Shoulders
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Novel sling
Traditional abduction sling
Kamuvudine-8Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
Sponsor:
University of Kentucky
Location:
Code:
NCT06164587
Conditions
Geographic Atrophy
Age-Related Macular Degeneration
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
K8
AXA1125Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
Sponsor:
Axcella Health, Inc
Location:
Code:
NCT04880187
Conditions
Non Alcoholic Steatohepatitis (NASH)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AXA1125
Placebo
WheezeScanClinical Validation of Omron WheezeScan
Sponsor:
Omron Healthcare Co., Ltd.
Location:
Code:
NCT04144699
Conditions
Asthma in Children
Bronchitis
Bronchiolitis
Eligibility Criteria
Sex: All
Age: 3 - 8
Healthy Volunteers: Not accepted